Candorium Free Members
Join Candorium to access the full article and more
Free Member Benefits:
✔
Comment & Reply✔
Newsletter Access✔
Follow Authors✔
Share via SMS Go Back
Sage Therapeutics to Report First Quarter 2025 Financial Results on Tuesday, April 29, 2025
By AP News - Apr 15, 2025, 06:31 AM ET
Last Updated - Apr 15, 2025, 06:31 AM EDT
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Apr 15, 2025--
Sage Therapeutics, Inc. (NASDAQ: SAGE) today announced that it will host a live webcast on Tuesday, April 29, 2025, at 4:30 p.m. ET to review first quarter 2025 financial results and discuss recent business updates.
The webcast can be accessed on the Investor page of Sage’s website at investor.sagerx.com. A replay of the webcast will be available following the completion of the event and will be archived for up to 30 days.
About Sage Therapeutics
Sage Therapeutics (Nasdaq: SAGE) is a biopharmaceutical company committed to our mission of pioneering solutions to deliver life-changing brain health medicines, so every person can thrive. Sage developed the only two FDA-approved treatments indicated for postpartum depression and is advancing a robust pipeline to target unmet needs in brain health. Sage was founded in 2010 and is headquartered in Cambridge, Mass. Find out more at www.sagerx.com or engage with us on Facebook, LinkedIn,Instagram, and X.
View source version on businesswire.com:https://www.businesswire.com/news/home/20250414189773/en/
CONTACT: Investor Contact
Ashley Kaplowitz
ashley.kaplowitz@sagerx.comMedia Contact
Francesca Dellelci
francesca.dellelci@sagerx.com
KEYWORD: UNITED STATES NORTH AMERICA MASSACHUSETTS
INDUSTRY KEYWORD: BIOTECHNOLOGY PHARMACEUTICAL HEALTH NEUROLOGY
Sponsored
SOURCE: Sage Therapeutics, Inc.
Copyright Business Wire 2025.
PUB: 04/15/2025 06:30 AM/DISC: 04/15/2025 06:30 AM
http://www.businesswire.com/news/home/20250414189773/en
Sponsored
Read More from Press Releases
Popular News
Latest News
